The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Update on Key Emerging Challenges in Cystic Fibrosis
Open accessAbstract
Cystic fibrosis (CF) is a multisystem disease causing severe chronic sinopulmonary disease and loss of pancreatic exocrine function, which affects approximately 70,000 individuals worldwide. New therapeutic developments over the last few decades have resulted in a significant increase in survival, with the median predicted survival now reaching the late thirties and more and more CF patients living well into adulthood. However, with this advent of new therapies and the associated increase in survival, new challenges in CF care have also emerged. Two of these challenges, i.e. chronic methicillin-resistant Staphylococcus aureus lung infection and patient adherence to very complicated and time-consuming therapeutic regimens, are reviewed in detail here. In addition, the ultimate challenge of treating the underlying cause of CF by correcting the dysfunction of the CF transmembrane conductance regulator chloride channel is reviewed, as agents to correct channel function will likely significantly alter CF clinical outcomes and treatment approaches in the next decade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Webb, A. K. (2006) · Cited by 4,369
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Interventions for enhancing medication adherence
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub3 · Cited by 1,244
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
PTC124 targets genetic disorders caused by nonsense mutations
Welch, E. M., Barton, E. R., Zhuo, J., Tomizawa, Y., Friesen, W. J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C. R., Hwang, S., et al. (2007) · Nature · doi:10.1038/nature05756 · Cited by 1,137
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
Research works printed but not linked: 5
- 10.1016/j.jcf.2009.11.009 · doi:10.1016/j.jcf.2009.11.009
- 10.1016/j.jhin.2003.12.003 · doi:10.1016/j.jhin.2003.12.003
- 10.1002/ppul.10231 · doi:10.1002/ppul.10231
- 10.1002/ppul.21315 · doi:10.1002/ppul.21315
- 10.1016/S0140-6736(12)60617-5 · doi:10.1016/s0140-6736(12)60617-5
Cited by
Items 101–200 of 234
Nonsense-Mediated mRNA Decay: Degradation of Defective Transcripts Is Only Part of the Story
He, F., & Jacobson, A. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-112414-054639 · Cited by 310
Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
Geller, D. E., Weers, J., & Heuerding, S. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0855 · Cited by 308
Localization of the cystic fibrosis transmembrane conductance regulator in pancreas.
Marino, C. R., Matovcik, L. M., Gorelick, F. S., & Cohn, J. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115358 · Cited by 307
Inhalation drug delivery devices: technology update
Garcia-Contreras, L., Ibrahim, M., & Verma, R. (2015) · Medical Devices: Evidence and Research · doi:10.2147/mder.s48888 · Cited by 306
Zemanick, E. T., Taylor-Cousar, J. L., Davies, J., Gibson, R. L., Mall, M. A., McKone, E. F., McNally, P., Ramsey, B. W., Rayment, J. H., Rowe, S. M., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202102-0509oc · Cited by 305
Franck, G., Mawson, T. L., Folco, E. J., Molinaro, R., Ruvkun, V., Engelbertsen, D., Liu, X., Tesmenitsky, Y., Shvartz, E., Sukhova, G. K., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312494 · Cited by 304
Mcdonald, C. M., Henricson, E. K., Abresch, R. T., Florence, J. M., Eagle, M., Gappmaier, E., Glanzman, A. M., PTC124‐GD‐007‐DMD Study Group, Spiegel, R., Barth, J., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23902 · Cited by 303
McElvaney, N. G., Nakamura, H., Birrer, P., Hébert, C. A., Wong, W. L., Alphonso, M., Baker, J. B., Catalano, M. A., & Crystal, R. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115994 · Cited by 299
Visualization of interaction between inorganic nanoparticles and bacteria or fungi
Chwalibog, Chwalibog, Sawosz, Hotowy, Szeliga, Mitura, S., Mitura, K., Grodzik, Orlowski, M., & Sokolowska, P. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s13532 · Cited by 298
Interventional tools to improve medication adherence: review of literature
Costa, E., Pecorelli, S., Giardini, A., Savin, M., Menditto, E., Lehane, E., Laosa, O., Monaco, A., & Marengoni, A. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s87551 · Cited by 295
Byström, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, U., Skogseid, B., Oberg, K., Werner, S., & Nordenskjöld, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1968 · Cited by 295
Clement, A. (2006) · Thorax · doi:10.1136/thx.2005.057950 · Cited by 292
CFTR modulator theratyping: Current status, gaps and future directions
Clancy, J. P., Cotton, C. U., Donaldson, S. H., Solomon, G. M., VanDevanter, D. R., Boyle, M. P., Gentzsch, M., Nick, J. A., Illek, B., Wallenburg, J. C., et al. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.05.004 · Cited by 291
Self-citationMucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery
Ensign, L. M., Schneider, C., Suk, J. S., Cone, R., & Hanes, J. (2012) · Advanced Materials · doi:10.1002/adma.201201800 · Cited by 290
Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review
De Vera, M. A., Bhole, V., Burns, L. C., & Lacaille, D. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12339 · Cited by 289
Smoking and microbiome in oral, airway, gut and some systemic diseases
Huang, C., & Shi, G. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1971-7 · Cited by 288
Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes
Barry, P. J., Mall, M. A., Álvarez, A., Colombo, C., de Winter-de Groot, K. M., Fajac, I., McBennett, K. A., McKone, E. F., Ramsey, B. W., Sutharsan, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100665 · Cited by 283
Freedman, S. D., Katz, M. H., Parker, E. M., Laposata, M., Urman, M. Y., & Alvarez, J. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13995 · Cited by 283
Ryan, R. E., Santesso, N., Lowe, D., Hill, S., Grimshaw, J. M., Prictor, M., Kaufman, C., Cowie, G., & Taylor, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007768.pub3 · Cited by 273
Strong, T. V., Boehm, K., & Collins, F. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116966 · Cited by 276
Rosenfeld, M., Wainwright, C. E., Higgins, M., Wang, L. T., McKee, C., Campbell, D., Tian, S., Schneider, J., Cunningham, S., Davies, J. C., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30202-9 · Cited by 273
Theory of planned behavior and adherence in chronic illness: a meta-analysis
Rich, A., Brandes, K., Mullan, B., & Hagger, M. S. (2015) · Journal of Behavioral Medicine · doi:10.1007/s10865-015-9644-3 · Cited by 272
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Robinson, E., MacDonald, K. D., Slaughter, K., McKinney, M., Patel, S., Sun, C., & Sahay, G. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.014 · Cited by 272
New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes
Zhao, Y.-Q., Zeng, D., Laber, E. B., & Kosorok, M. R. (2015) · Journal of the American Statistical Association · doi:10.1080/01621459.2014.937488 · Cited by 267
Prevention and treatment of Staphylococcus aureus biofilms
Bhattacharya, M., Wozniak, D. J., Stoodley, P., & Hall-Stoodley, L. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1100533 · Cited by 265
Key mechanisms governing resolution of lung inflammation
Robb, C. T., Regan, K. H., Dorward, D. A., & Rossi, A. G. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0560-6 · Cited by 261
Okada-Katsuhata, Y., Yamashita, A., Kutsuzawa, K., Izumi, N., Hirahara, F., & Ohno, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr791 · Cited by 255
Cystic fibrosis: a clinical view
Castellani, C., & Assael, B. M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2393-9 · Cited by 254
Genomic Medicine–Progress, Pitfalls, and Promise
Shendure, J., Findlay, G. M., & Snyder, M. W. (2019) · Cell · doi:10.1016/j.cell.2019.02.003 · Cited by 254
Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis
Parkins, M. D., Somayaji, R., & Waters, V. J. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-18 · Cited by 253
Structural identification of a hotspot on CFTR for potentiation
Liu, F., Zhang, Z., Levit, A., Levring, J., Touhara, K. K., Shoichet, B. K., & Chen, J. (2019) · Science · doi:10.1126/science.aaw7611 · Cited by 253
Pantoja, T., Opiyo, N., Lewin, S., Paulsen, E., Ciapponi, A., Wiysonge, C. S., Herrera, C. A., Rada, G., Peñaloza, B., Dudley, L., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011086.pub2 · Cited by 252
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
Hutt, D. M., Herman, D., Rodrigues, A. P. C., Noel, S., Pilewski, J. M., Matteson, J., Hoch, B., Kellner, W., Kelly, J. W., Schmidt, A., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.275 · Cited by 252
Nick, J. A., Dedrick, R. M., Gray, A. L., Vladar, E. K., Smith, B. E., Freeman, K. G., Malcolm, K. C., Epperson, L. E., Hasan, N. A., Hendrix, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.024 · Cited by 251
Ramos, K. J., Smith, P. J., McKone, E. F., Pilewski, J. M., Lucy, A., Hempstead, S. E., Tallarico, E., Faro, A., Rosenbluth, D. B., Gray, A. L., et al. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.03.002 · Cited by 227
Do you know the sex of your cells?
Shah, K., McCormack, C. E., & Bradbury, N. A. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00281.2013 · Cited by 219
Bessonova, L., Volkova, N., Higgins, M., Bengtsson, L., Tian, S., Simard, C., Konstan, M. W., Sawicki, G. S., Sewall, A., Nyangoma, S., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210394 · Cited by 214
Badawy, S. M., Barrera, L., Sinno, M. G., Kaviany, S., O’Dwyer, L. C., & Kuhns, L. M. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.7798 · Cited by 207
Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial
Choudhry, N. K., Krumme, A. A., Ercole, P. M., Girdish, C., Tong, A. Y., Khan, N. F., Brennan, T. A., Matlin, O. S., Shrank, W. H., & Franklin, J. M. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9627 · Cited by 199
Desroches, S., Lapointe, A., Ratté, S., Gravel, K., Légaré, F., & Turcotte, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008722.pub2 · Cited by 187
Smith, C., Vannak, U., Sokhey, L., Ngo, T. D., Gold, J., & Free, C. (2015) · Reproductive Health · doi:10.1186/s12978-015-0112-x · Cited by 179
Demain, S., Gonçalves, A.-C., Areia, C., Oliveira, R., Marcos, A. J., Marques, A., Parmar, R., & Hunt, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125457 · Cited by 173
Pranke, I. M., Hatton, A., Simonin, J., Jais, J. P., Le Pimpec-Barthes, F., Carsin, A., Bonnette, P., Fayon, M., Stremler-Le Bel, N., Grenet, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07504-1 · Cited by 161
Law, E. F., Fisher, E., Fales, J., Noel, M., & Eccleston, C. (2014) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsu032 · Cited by 159
Kamal, A. K., Shaikh, Q., Pasha, O., Azam, I., Islam, M., Memon, A. A., Rehman, H., Akram, M. A., Affan, M., Nazir, S., et al. (2015) · BMC Neurology · doi:10.1186/s12883-015-0471-5 · Cited by 159
Painter, K. L., Strange, E., Parkhill, J., Bamford, K. B., Armstrong-James, D., & Edwards, A. M. (2015) · Infection and Immunity · doi:10.1128/iai.03016-14 · Cited by 153
Psychosocial Late Effects in Pediatric Cancer Survivors: A Report From the Children's Oncology Group
Bitsko, M. J., Cohen, D., Dillon, R., Harvey, J., Krull, K., & Klosky, J. L. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25773 · Cited by 148
Mahley, R. W., & Huang, Y. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3008618 · Cited by 132
Loureiro, A., & da Silva, G. J. (2019) · Antibiotics · doi:10.3390/antibiotics8010018 · Cited by 129
Duytschaever, G., Huys, G., Bekaert, M., Boulanger, L., De Boeck, K., & Vandamme, P. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05933-11 · Cited by 114
Moisan, H., Brouillette, E., Jacob, C. L., Langlois-Bégin, P., Michaud, S., & Malouin, F. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.1.64-76.2006 · Cited by 116
Deppisch, C., Herrmann, G., Graepler-Mainka, U., Wirtz, H., Heyder, S., Engel, C., Marschal, M., Miller, C. C., & Riethmüller, J. (2016) · Infection · doi:10.1007/s15010-016-0879-x · Cited by 115
Interventions for helping people adhere to compression treatments for venous leg ulceration
Weller, C. D., Buchbinder, R., & Johnston, R. V. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008378.pub3 · Cited by 114
Cushing, C. C., Brannon, E. E., Suorsa, K. I., & Wilson, D. K. (2014) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsu042 · Cited by 110
(1997) · PubMed · Cited by 112
A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs
Scales, B. S., Dickson, R. P., & Huffnagle, G. B. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0316-106r · Cited by 109
Sanders, D. B., & Fink, A. K. (2016) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2016.04.001 · Cited by 109
Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies
Brewington, J. J., Filbrandt, E. T., LaRosa, F. J., Moncivaiz, J. D., Ostmann, A. J., Strecker, L. M., & Clancy, J. P. (2018) · JCI Insight · doi:10.1172/jci.insight.99385 · Cited by 106
Taylor-Cousar, J. L., Mall, M. A., Ramsey, B. W., McKone, E. F., Tullis, E., Marigowda, G., McKee, C. M., Waltz, D., Moskowitz, S. M., Savage, J., et al. (2019) · ERJ Open Research · doi:10.1183/23120541.00082-2019 · Cited by 105
Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
Sahu, I., Haque, A. K. M. A., Weidensee, B., Weinmann, P., & Kormann, M. S. D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.019 · Cited by 104
Dornase alfa for cystic fibrosis
Yang, C., & Montgomery, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001127.pub4 · Cited by 101
Daines, C. L., Tullis, E., Costa, S., Linnemann, R. W., Mall, M. A., McKone, E. F., Polineni, D., Quon, B. S., Ringshausen, F. C., Rowe, S. M., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.02029-2022 · Cited by 100
Keyloun, K. R., Hansen, R. N., Hepp, Z., Gillard, P., Thase, M. E., & Devine, E. B. (2017) · CNS Drugs · doi:10.1007/s40263-017-0417-0 · Cited by 99
Plevinsky, J., Greenley, R., & Fishman, L. (2016) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s106302 · Cited by 99
Amankwaa, I., Boateng, D., Quansah, D. Y., Akuoko, C. P., & Evans, C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204091 · Cited by 98
Systematic Review of Digital Interventions for Pediatric Asthma Management
Ramsey, R. R., Plevinsky, J. M., Kollin, S. R., Gibler, R. C., Guilbert, T. W., & Hommel, K. A. (2020) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.12.013 · Cited by 95
Psychological interventions for individuals with cystic fibrosis and their families
Goldbeck, L., Fidika, A., Herle, M., & Quittner, A. L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003148.pub3 · Cited by 94
Tosco, A., De Gregorio, F., Esposito, S., De Stefano, D., Sana, I., Ferrari, E., Sepe, A., Salvadori, L., Buonpensiero, P., Di Pasqua, A., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.22 · Cited by 92
Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis
Smith, S., Rowbotham, N. J., & Regan, K. H. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001021.pub3 · Cited by 92
Awatade, N. T., Wong, S. L., Hewson, C. K., Fawcett, L. K., Kicic, A., Jaffe, A., & Waters, S. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01429 · Cited by 92
Sanz, D. J., Hollywood, J. A., Scallan, M. F., & Harrison, P. T. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184009 · Cited by 92
Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR
Rowe, S. M., McColley, S. A., Rietschel, E., Li, X., Bell, S. C., Konstan, M. W., Marigowda, G., Waltz, D., & Boyle, M. P. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201609-689oc · Cited by 92
Self-citationNhavoto, J. A., Grönlund, Å., & Klein, G. O. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176051 · Cited by 91
Achaval, S. D., & Suarez-Almazor, M. E. (2010) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.10.15 · Cited by 90
Beyond Endometriosis Genome-Wide Association Study: From Genomics to Phenomics to the Patient
Rahmioglu, N., Morris, A., Nyholt, D., Montgomery, G., Becker, C., Missmer, S., & Zondervan, K. (2016) · Seminars in Reproductive Medicine · doi:10.1055/s-0036-1585408 · Cited by 84
Shimizu-Motohashi, Y., Komaki, H., Motohashi, N., Takeda, S., Yokota, T., & Aoki, Y. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9010001 · Cited by 82
Molecular Therapies for Inherited Retinal Diseases—Current Standing, Opportunities and Challenges
Vázquez-Domínguez, I., Garanto, A., & Collin, R. W. J. (2019) · Genes · doi:10.3390/genes10090654 · Cited by 80
Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis
Haque, A. K. M. A., Dewerth, A., Antony, J. S., Riethmüller, J., Schweizer, G. R., Weinmann, P., Latifi, N., Yasar, H., Pedemonte, N., Sondo, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34960-0 · Cited by 80
Goldfeder, R. L., Wall, D. P., Khoury, M. J., Ioannidis, J. P. A., & Ashley, E. A. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kww224 · Cited by 75
Beversdorf, D. Q., & MISSOURI AUTISM SUMMIT CONSORTIUM* (2016) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000351 · Cited by 74
Insights into assessing the genetics of endometriosis
Rahmioglu, N., Missmer, S. A., Montgomery, G. W., & Zondervan, K. T. (2012) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-012-0016-5 · Cited by 71
Air-Liquid interface cultures to model drug delivery through the mucociliary epithelial barrier
Lee, R. E., Reidel, B., Nelson, M. R., Macdonald, J. K., Kesimer, M., & Randell, S. H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114866 · Cited by 71
Haas, K., Martin, A., & Park, K. T. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.02.062 · Cited by 70
Pulmonary Exacerbations in Adults With Cystic Fibrosis
Stanford, G. E., Dave, K., & Simmonds, N. J. (2021) · Chest · doi:10.1016/j.chest.2020.09.084 · Cited by 70
Bulcaen, M., Kortleven, P., Liu, R. B., Maule, G., Dreano, E., Kelly, M., Ensinck, M. M., Thierie, S., Smits, M., Ciciani, M., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101544 · Cited by 69
Medication adherence and resistant hypertension
Hyman, D. J., & Pavlik, V (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.73 · Cited by 61
Tagalakis, A. D., Munye, M. M., Ivanova, R., Chen, H., Smith, C. M., Aldossary, A. M., Rosa, L. Z., Moulding, D., Barnes, J. L., Kafetzis, K. N., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210670 · Cited by 61
Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis.
Hong, G., Psoter, K. J., Jennings, M. T., Merlo, C. A., Boyle, M. P., Hadjiliadis, D., Kawut, S. M., & Lechtzin, N. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.01.008 · Cited by 59
Self-citation(1993) · Europe PMC (PubMed Central) · Cited by 59
Patient-centered priorities for improving medication management and adherence
McMullen, C. K., Safford, M. M., Bosworth, H. B., Phansalkar, S., Leong, A., Fagan, M. B., Trontell, A., Rumptz, M., Vandermeer, M. L., Brinkman, W. B., et al. (2015) · Patient Education and Counseling · doi:10.1016/j.pec.2014.09.015 · Cited by 58
Wildman, M. J., O’Cathain, A., Maguire, C., Arden, M. A., Hutchings, M., Bradley, J., Walters, S. J., Whelan, P., Ainsworth, J., Buchan, I., et al. (2022) · Thorax · doi:10.1136/thoraxjnl-2021-217594 · Cited by 54
Tse, C.-M., Yin, J., Singh, V., Sarker, R., Lin, R., Verkman, A. S., Turner, J. R., & Donowitz, M. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.01.002 · Cited by 53
Reighard, K. P., Hill, D. B., Dixon, G. A., Worley, B. V., & Schoenfisch, M. H. (2015) · Biofouling · doi:10.1080/08927014.2015.1107548 · Cited by 53
Psychosocial interventions for the diabetic patient
Harvey, J. (2015) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s44352 · Cited by 52
Rapid therapeutic advances in CFTR modulator science
Clancy, J. P. (2018) · Pediatric Pulmonology · doi:10.1002/ppul.24157 · Cited by 52
Tsuji, B. T., von Eiff, C., Kelchlin, P. A., Forrest, A., & Smith, P. F. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01254-07 · Cited by 51
Zhang, W., Collins, A., Gibson, J., Tapper, W. J., Hunt, S., Deloukas, P., Bentley, D. R., & Morton, N. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408251102 · Cited by 49
Kotagama, O. W., Jayasinghe, C. D., & Abeysinghe, T. (2019) · BioMed Research International · doi:10.1155/2019/1369682 · Cited by 48
Arden, M. A., Hutchings, M., Whelan, P., Drabble, S. J., Beever, D., Bradley, J. M., Hind, D., Ainsworth, J., Maguire, C., Cantrill, H., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00739-2 · Cited by 44
Efficacy of digital health interventions in youth with chronic medical conditions: A meta-analysis
Domhardt, M., Schröder, A., Geirhos, A., Steubl, L., & Baumeister, H. (2021) · Internet Interventions · doi:10.1016/j.invent.2021.100373 · Cited by 45
Metadata
- Authors
- Jennings, M. T., Riekert, K. A., & Boyle, M. P.
- Venue
- Medical Principles and Practice
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 23
- Issue
- 5
- Pages
- 393-402
- ISSN
- 1011-7571 (ISSN-L)
- 1423-0151
- OpenAlex
- W2078078890
- Cited by
- 3,648
- References
- 81
- FWCI
- 259.52
- Type
- journal article
- Language
- en
- Open access
- diamond
- Licence
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.